Diagnosis and treatment of a typical and anaplastic meningiomas: A review

被引:242
作者
Modha, A
Gutin, PH
机构
[1] Mem Sloan Kettering Canc Ctr, Neurol Serv, New York, NY 10021 USA
[2] Cornell Univ, Dept Neurol Surg, Weill Med Coll, New York, NY USA
关键词
atypical meningiomas; anaplastic meningiomas; stereotactic radiosurgery; brachytherapy;
D O I
10.1227/01.NEU.0000170980.47582.A5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ATYPICAL AND ANAPLASTIC meningiomas are uncommon tumors with a poorer prognosis than benign meningiomas. We reviewed the current literature and attempted to integrate and summarize available information to determine a logical approach to these tumors. Both tumors are rare and are often integrated with benign meningiomas when treatments are evaluated. In addition, because there has not been one histopathological classification scheme for atypical and anaplastic meningiomas in the past, there are numerous inconsistencies in the literature. Malignant progression with accumulation of mutations in a benign meningioma can result in an atypical and/or anaplastic meningioma. Both tumors are difficult to manage and have high recurrence and poor survival rates. The extent of tumor resection and histological grade are the key determinants for recurrence. In addition, metastases are unusual, but they do occur. We also review the evidence available that has resulted in the current World Health Organization classification. Radiation therapy can be used as an adjunctive treatment after both total and subtotal resection. In addition, the role of stereotactic radiosurgery is increasing, along with a possible role for brachytherapy. There are no effective chemotherapeutic agents available. A treatment algorithm is suggested.
引用
收藏
页码:538 / 549
页数:12
相关论文
共 68 条
[1]   MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: A study of 90 tumors [J].
Abramovich, CM ;
Prayson, RA .
HUMAN PATHOLOGY, 1998, 29 (12) :1420-1427
[2]   Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings [J].
Al-Mefty, O ;
Kadri, PAS ;
Pravdenkova, S ;
Sawyer, JR ;
Stangeby, C ;
Husain, M .
JOURNAL OF NEUROSURGERY, 2004, 101 (02) :210-218
[3]   Radiation-induced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics [J].
Al-Mefty, O ;
Topsakal, C ;
Pravdenkova, S ;
Sawyer, JR ;
Harrison, MJ .
JOURNAL OF NEUROSURGERY, 2004, 100 (06) :1002-1013
[4]   PLATELET-DERIVED GROWTH-FACTOR EXPRESSION AND STIMULATION IN HUMAN MENINGIOMAS [J].
BLACK, PM ;
CARROLL, R ;
GLOWACKA, D ;
RILEY, K ;
DASHNER, K .
JOURNAL OF NEUROSURGERY, 1994, 81 (03) :388-393
[5]   Alterations of the tumor suppressor genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in atypical and anaplastic meningiomas [J].
Boström, J ;
Meyer-Puttlitz, B ;
Wolter, M ;
Blaschke, B ;
Weber, RG ;
Lichter, P ;
Ichimura, K ;
Collins, VP ;
Reifenberger, G .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (02) :661-669
[6]   Adjuvant combined modality therapy for malignant meningiomas [J].
Chamberlain, MC .
JOURNAL OF NEUROSURGERY, 1996, 84 (05) :733-736
[7]   1H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors [J].
Cho, YD ;
Choi, GH ;
Lee, SP ;
Kim, JK .
MAGNETIC RESONANCE IMAGING, 2003, 21 (06) :663-672
[8]  
DEAN BL, 1994, AM J NEURORADIOL, V15, P1675
[9]   Malignant meningioma: An indication for initial aggressive surgery and adjuvant radiotherapy [J].
Dziuk, TW ;
Woo, S ;
Butler, EB ;
Thornby, J ;
Grossman, R ;
Dennis, WS ;
Lu, H ;
Carpenter, LS ;
Chiu, JK .
JOURNAL OF NEURO-ONCOLOGY, 1998, 37 (02) :177-188
[10]  
Filippi CG, 2001, AM J NEURORADIOL, V22, P65